These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34880319)

  • 1. Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes.
    Antonopoulos AS; Boutsikou M; Simantiris S; Angelopoulos A; Lazaros G; Panagiotopoulos I; Oikonomou E; Kanoupaki M; Tousoulis D; Mohiaddin RH; Tsioufis K; Vlachopoulos C
    Sci Rep; 2021 Dec; 11(1):23596. PubMed ID: 34880319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture signatures of native myocardial T
    Neisius U; El-Rewaidy H; Kucukseymen S; Tsao CW; Mancio J; Nakamori S; Manning WJ; Nezafat R
    J Magn Reson Imaging; 2020 Sep; 52(3):906-919. PubMed ID: 31971296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic Analysis of Native T
    Wang J; Yang F; Liu W; Sun J; Han Y; Li D; Gkoutos GV; Zhu Y; Chen Y
    J Magn Reson Imaging; 2020 Dec; 52(6):1714-1721. PubMed ID: 32525266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
    Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics.
    Jiang S; Zhang L; Wang J; Li X; Hu S; Fu Y; Wang X; Hao S; Hu C
    Front Cardiovasc Med; 2022; 9():1001269. PubMed ID: 36386316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic Analysis of Myocardial Native T
    Neisius U; El-Rewaidy H; Nakamori S; Rodriguez J; Manning WJ; Nezafat R
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1946-1954. PubMed ID: 30660549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy.
    Mancio J; Pashakhanloo F; El-Rewaidy H; Jang J; Joshi G; Csecs I; Ngo L; Rowin E; Manning W; Maron M; Nezafat R
    Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):532-542. PubMed ID: 33779725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
    Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics of Non-Contrast-Enhanced T1 Mapping: Diagnostic and Predictive Performance for Myocardial Injury in Acute ST-Segment-Elevation Myocardial Infarction.
    Ma Q; Ma Y; Yu T; Sun Z; Hou Y
    Korean J Radiol; 2021 Apr; 22(4):535-546. PubMed ID: 33289360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-contrast Cine Cardiac Magnetic Resonance image radiomics features and machine learning algorithms for myocardial infarction detection.
    Avard E; Shiri I; Hajianfar G; Abdollahi H; Kalantari KR; Houshmand G; Kasani K; Bitarafan-Rajabi A; Deevband MR; Oveisi M; Zaidi H
    Comput Biol Med; 2022 Feb; 141():105145. PubMed ID: 34929466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance radiomics for disease classification.
    Zhang X; Cui C; Zhao S; Xie L; Tian Y
    Eur Radiol; 2023 Apr; 33(4):2312-2323. PubMed ID: 36378251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy.
    Huang S; Shi K; Zhang Y; Yan WF; Guo YK; Li Y; Yang ZG
    BMC Cardiovasc Disord; 2022 May; 22(1):235. PubMed ID: 35597906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy.
    Arcari L; Hinojar R; Engel J; Freiwald T; Platschek S; Zainal H; Zhou H; Vasquez M; Keller T; Rolf A; Geiger H; Hauser I; Vogl TJ; Zeiher AM; Volpe M; Nagel E; Puntmann VO
    Int J Cardiol; 2020 May; 306():102-108. PubMed ID: 32169347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy.
    Chang S; Han K; Kwon Y; Kim L; Hwang S; Kim H; Choi BW
    Korean J Radiol; 2023 May; 24(5):395-405. PubMed ID: 37133210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
    Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
    Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.